Citation Impact
Citing Papers
Zone Electrophoresis in Starch Gels and its Application to Studies of Serum Proteins
1959 StandoutNobel
Pharmacokinetic observations of phenytoin disposition in the newborn and young infant.
1977
Glutamate receptor ion channels
2005 Standout
Non-motor symptoms of Parkinson's disease: diagnosis and management
2006 Standout
Glutamate Receptor Ion Channels: Structure, Regulation, and Function
2010 Standout
Pharmacology and Management of the Vitamin K Antagonists
2008 Standout
Antiepileptic drugs—best practice guidelines for therapeutic drug monitoring: A position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies
2008
DST abnormality as a predictor of course in major depression
1990
Dietary Intake and Bioavailability of Polyphenols
2000 Standout
Neural Synchrony in Brain Disorders: Relevance for Cognitive Dysfunctions and Pathophysiology
2006 Standout
Dose calculation of anticancer drugs: a review of the current practice and introduction of an alternative.
1996 Standout
Non-compliance—or how many aunts has Matilda?
1993 Standout
Cytochrome P450 2C9 polymorphisms: a comprehensive review of the in-vitro and human data
2002
Genetic Polymorphisms of HumanN-Acetyltransferase, Cytochrome P450, Glutathione-S-Transferase, and Epoxide Hydrolase Enzymes: Relevance to Xenobiotic Metabolism and Toxicity
1999
The formalin test in mice: dissociation between inflammatory and non-inflammatory pain
1987 Standout
Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline
2016 Standout
Chemical models of epilepsy with some reference to their applicability in the development of anticonvulsants
1992
GABAA Receptor Channels
1994 Standout
Mortality and Morbidity in Patients Receiving Encainide, Flecainide, or Placebo
1991 Standout
Encephalitogenic T cells in the B10.PL model of experimental allergic encephalomyelitis (EAE) are of the Th-1 lymphokine subtype
1989
Risk factors for suicidal thoughts and behaviors: A meta-analysis of 50 years of research.
2016 Standout
Drug assay using antibody mimics made by molecular imprinting
1993 StandoutNature
PSYCHOPHARMACOLOGIC TREATMENT OF PATHOLOGIC AGGRESSION
1997
BEHAVIORAL ENGINEERING: THE USE OF RESPONSE PRIMING TO IMPROVE PRESCRIBED SELF‐MEDICATION1
1969
Induction of rat liver microsomal cytochrome P-450 by the pentabromo diphenyl ether Bromkal 70 and half-lives of its components in the adipose tissue
1990
Manganese action in brain function
2003
An overview of brominated flame retardants in the environment
2002 Standout
Oral Anticoagulants: Mechanism of Action, Clinical Effectiveness, and Optimal Therapeutic Range
2001 Standout
Severe Adverse Cutaneous Reactions to Drugs
1994 Standout
A General Method of Compliance Assessment Using Centralized Pharmacy Records
1988
Psychiatric Aspects of Impulsivity
2001 Standout
Muscle weakness in intensive care patients: Initial manifestation of vitamin D deficiency
1994
Antithrombotic Therapy for Venous Thromboembolic Disease
2001 Standout
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Bioluminescent sensor proteins for point-of-care therapeutic drug monitoring
2014 StandoutNobel
Motor recovery after stroke: a systematic review
2009 Standout
Developmental Pharmacology — Drug Disposition, Action, and Therapy in Infants and Children
2003 Standout
Insulin in blood and insulin antibodies
1966 StandoutNobel
Pharmacogenetics of mephenytoin: A new drug hydroxylation polymorphism in man
1984
Economic Status and Health in Childhood: The Origins of the Gradient
2002 Standout
Relationship between structure and convulsant properties of some beta-lactam antibiotics following intracerebroventricular microinjection in rats
1995
Abnormal performance on the PD test battery by asymptomatic first-degree relatives
1999
Further Studies on the Nature of Immunoreactive Gastrin in Human Plasma
1971 StandoutNobel
Management of Parkinson's disease: An evidence-based review
2002
Screening procedure for benzodiazepines in biological fluids by high-performance liquid chromatography using a rapid-scanning multichannel detector
1987
Vitamin D Deficiency and Secondary Hyperparathyroidism in the Elderly: Consequences for Bone Loss and Fractures and Therapeutic Implications
2001 Standout
A novel approach to stroke rehabilitation
2000
Enzyme Immunoassays in Clinical Chemistry: Present Status and Trends
1980
Limbic seizure and brain damage produced by kainic acid: Mechanisms and relevance to human temporal lobe epilepsy
1985 Standout
Predisposition to Phenytoin Hepatotoxicity Assessed in Vitro
1981
Maternal and fetal sequelae of anticoagulation during pregnancy
1980
DISC ELECTROPHORESIS – II METHOD AND APPLICATION TO HUMAN SERUM PROTEINS*
1964 Standout
DISC ELECTROPHORESIS‐I BACKGROUND AND THEORY*
1964 Standout
Zinc‐Induced Seizures: A New Experimental Model of Epilepsy
1983
State of Human Growth Hormone in Plasma and Changes in Stored Solutions of Pituitary Growth Hormone
1966 StandoutNobel
Phosvitin Kinase from the Liver of the Rooster
1973 StandoutNobel
Studies on the Distribution and Degradation of Heptadecapeptide, Big, and Big Big Gastrin
1974 StandoutNobel
A Controlled Therapeutic Study of the Irritable-Bowel Syndrome
1973
Revised methods for the Salmonella mutagenicity test
1983 Standout
Induction of rat liver enzymes by polychlorinated biphenyls (PCBs) in dependence on the dose and chlorine content
1974
Defective N-oxidation of sparteine in man: A new pharmacogenetic defect
1979
Radioimmunoassay of somatomedin B. Application to clinical and physiologic studies.
1975 StandoutNobel
Carbamazepine and its 10,11-epoxide in children and adults with epilepsy
1977
Size and Charge Distinctions Between Endogenous Human Plasma Gastrin in Peripheral Blood and Heptadecapeptide Gastrins
1970 StandoutNobel
Fluorescent Sensors for Measuring Metal Ions in Living Systems
2014 Standout
Michaelis-Menten pharmacokinetics of diphenylhydantoin and application in the pediatric age patient
1980
Sex-Related Differences in Drug Metabolism
1975
Effect on survival after myocardial infarction of long-term treatment with phenytoin.
1978
Kinetics of open channel block by penicillin of single GABAA receptor channels from mouse spinal cord neurones in culture.
1992
Penetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System Infections
2010 Standout
How Often Is Medication Taken as Prescribed?
1989 Standout
Iodoinsulin Used To Determine Specific Activity of Iodine-131
1966 StandoutScienceNobel
Substrate interaction with cytochrome P-450
1981
Drug Disposition in Obese Humans
1986
Lidocaine Pharmacokinetics in Advanced Heart Failure, Liver Disease, and Renal Failure in Humans
1973
Nature of Immunoreactive Gastrin Extracted from Tissues of Gastrointestinal Tract
1971 StandoutNobel
Case Report: Adverse Effect of Phenytoin on Mineralocorticoid Replacement with Fludrocortisone in Adrenal Insufficiency
1986
A Review of Enzyme Induction of Warfarin Metabolism with Recommendations for Patient Management
1997
Radioimmunoassay of gastrin
1970 StandoutNobel
Tissue-specific expression of B7x protects from CD4 T cell–mediated autoimmunity
2011 StandoutNobel
Medication Adherence
2009 Standout
Epileptic seizure disorders
1985
Methods for detecting carcinogens and mutagens with the salmonella/mammalian-microsome mutagenicity test
1975 Standout
Part 14: Pediatric Advanced Life Support
2010 Standout
Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosis
1986 Standout
Antibodies to Human Growth Hormone (HGH) in Human Subjects Treated with HGH*
1964 StandoutNobel
Functional bowel disorders in apparently healthy people
1980 Standout
Pediatric Patients With Undetectable Anticonvulsant Blood Levels: Comparison With Compliant Patients
2001
Phosvitin kinase from brain: activation by ions and subcellular distribution
1964
Structure and Chemistry of Cytochrome P450
2005 Standout
Works of Henn Kutt being referenced
DIPHENYLHYDANTOIN METABOLISM BY RAT LIVER MICROSOMES AND SOME OF THE EFFECTS OF DRUG OR CHEMICAL PRETREATMENT ON DIPHENYLHYDANTOIN METABOLISM BY RAT LIVER MICROSOMAL PREPARATIONS
1971
THE EFFECTS OF SOME STIMULATORS (INDUCERS) OF HEPATIC MICROSOMAL DRUG-METABOLIZING ENZYME ACTIVITY ON SUBSTRATE-INDUCED DIFFERENCE SPECTRA IN RAT LIVER MICROSOMES
1971
3,4-Diaminopyridine as a treatment for amyotrophic lateral sclerosis
1995
Felbamate Levels in Patients with Epilepsy
1996
Intravenous diphenylhydantoin in treatment of acute repetitive seizures
1998
Seizure disorders and trace metals
1979
Antiepileptic Therapy
1980
Management of Epilepsy With Diphenylhydantoin Sodium
1968
CARBAMAZEPINE IN DIFFICULT TO CONTROL EPILEPTIC OUT-PATIENTS
1975
Practical Neurochemistry.
1962
Improved gas chromatographic procedure for the determination of clonazepam levels in plasma using a nitrogen-sensitive detector
1981
Usefulness of Blood Levels of Antiepileptic Drugs
1974
Zone Electrophoresis of Cerebrospinal Fluid Proteins in Starch Gel.
1958
Phenytoin: relevant side effects.
1980
Anticonvulsant Therapy. Pharmacological Basis and Practice
1981
Treatment outcome in elderly depressives: plasma nortriptyline concentration and pretreatment dexamethasone suppression test.
1984
Some Causes of Ineffectiveness of Diphenylhydantoin
1966
Neurotoxicity of Intravenously Administered Penicillin G
1971
Intravenous diphenylhydantoin in treatment of acute repetitive seizures
1968
Controlled‐release levodopa/carbidopa.
1987
Relationship Between the Plasma Level of Diphenylhydantoin Sodium and Its Cardiac Antiarrhythmic Effects
1968
Sustained enteral administration of levodopa increases and interrupted infusion decreases levodopa dose requirement
1990
Insufficient parahydroxylation as a cause of diphenylhydantoin toxicity
1964
Diphenylhydantoin in children
1973
Methods of Analysis of Antiepileptic Drugs
1974
Diphenylhydantoin Metabolism, Blood Levels, and Toxicity
1964
Coagulation defects caused by diphenylhydantoin
1972
Management of epilepsy with diphenylhydantoin sodium. Dosage regulation for problem patients
1968
Diphenylhydantoin: Efficacy, toxicity, and dose-serum level relationships in children
1972
Correlation of the “EMIT” with a Gas-Liquid Chromatographic Method for Determination of Antiepileptic Drugs in Plasma
1978